The role of soluble Guanylyl Cyclase in chronic obstructive pulmonary disease

Constantinos Glynos, Lisa L. Dupont, Theodoros Vassilakopoulos, Andreas Papapetropoulos, Peter Brouckaert, Athanassios Giannis, Guy F. Joos, Ken R. Bracke, Guy G. Brusselle

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Rationale: Soluble guanylyl cyclase (sGC), a cyclic guanosine 59-monophosphategenerating enzyme, regulates smooth muscle toneandexerts antiinflammatoryeffects in animal modelsof asthma and acute lung injury. In chronic obstructive pulmonary disease (COPD), primarily caused by cigarette smoke (CS), lung inflammation persists and smooth muscle tone remains elevated, despite ample amounts of nitric oxide that could activate sGC. Objectives: To determine the expression and function of sGCin patients with COPD and in a murine model of COPD. Methods: Expression of sGCa1, a2, and b1 subunits was examined in lungs of never-smokers, smokers without airflow limitation, and patients with COPD; and in C57BL/6 mice after 3 days, 4 weeks, and 24 weeks of CS exposure. The functional role of sGC was investigated in vivo by measuring bronchial responsiveness to serotonin in mice using genetic and pharmacologic approaches. Measurements and Main Results: Pulmonary expression of sGC, both at mRNA and protein level, was decreased in smokers without airflow limitation and in patients with COPD, and correlated with disease severity (FEV1%). Inmice, exposure to CS reduced sGC, cyclic guanosine 59-monophosphate levels, and protein kinase G activity. sGCa12/2 mice exposed to CS exhibited bronchial hyperresponsiveness to serotonin. Activation of sGC by BAY 58-2667 restored the sGC signaling and attenuated bronchial hyperresponsiveness in CS-exposed mice. Conclusions: Down-regulation of sGC because of CS exposure might contribute to airflow limitation in COPD.

Original languageEnglish (US)
Pages (from-to)789-799
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume188
Issue number7
DOIs
StatePublished - Oct 1 2013
Externally publishedYes

Fingerprint

Chronic Obstructive Pulmonary Disease
Smoke
Tobacco Products
Smooth Muscle
Serotonin
Cyclic GMP-Dependent Protein Kinases
Lung
Soluble Guanylyl Cyclase
Guanosine
Acute Lung Injury
Cyclic GMP
Inbred C57BL Mouse
Pneumonia
Nitric Oxide
Down-Regulation
Asthma
Messenger RNA
Enzymes
Proteins

Keywords

  • Chronic obstructive pulmonary disease
  • Cigarette smoking
  • Soluble guanylyl cyclase

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

The role of soluble Guanylyl Cyclase in chronic obstructive pulmonary disease. / Glynos, Constantinos; Dupont, Lisa L.; Vassilakopoulos, Theodoros; Papapetropoulos, Andreas; Brouckaert, Peter; Giannis, Athanassios; Joos, Guy F.; Bracke, Ken R.; Brusselle, Guy G.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 188, No. 7, 01.10.2013, p. 789-799.

Research output: Contribution to journalArticle

Glynos, C, Dupont, LL, Vassilakopoulos, T, Papapetropoulos, A, Brouckaert, P, Giannis, A, Joos, GF, Bracke, KR & Brusselle, GG 2013, 'The role of soluble Guanylyl Cyclase in chronic obstructive pulmonary disease', American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 7, pp. 789-799. https://doi.org/10.1164/rccm.201210-1884OC
Glynos, Constantinos ; Dupont, Lisa L. ; Vassilakopoulos, Theodoros ; Papapetropoulos, Andreas ; Brouckaert, Peter ; Giannis, Athanassios ; Joos, Guy F. ; Bracke, Ken R. ; Brusselle, Guy G. / The role of soluble Guanylyl Cyclase in chronic obstructive pulmonary disease. In: American Journal of Respiratory and Critical Care Medicine. 2013 ; Vol. 188, No. 7. pp. 789-799.
@article{7ea9631ec3604cf694a9c84754b7ddc1,
title = "The role of soluble Guanylyl Cyclase in chronic obstructive pulmonary disease",
abstract = "Rationale: Soluble guanylyl cyclase (sGC), a cyclic guanosine 59-monophosphategenerating enzyme, regulates smooth muscle toneandexerts antiinflammatoryeffects in animal modelsof asthma and acute lung injury. In chronic obstructive pulmonary disease (COPD), primarily caused by cigarette smoke (CS), lung inflammation persists and smooth muscle tone remains elevated, despite ample amounts of nitric oxide that could activate sGC. Objectives: To determine the expression and function of sGCin patients with COPD and in a murine model of COPD. Methods: Expression of sGCa1, a2, and b1 subunits was examined in lungs of never-smokers, smokers without airflow limitation, and patients with COPD; and in C57BL/6 mice after 3 days, 4 weeks, and 24 weeks of CS exposure. The functional role of sGC was investigated in vivo by measuring bronchial responsiveness to serotonin in mice using genetic and pharmacologic approaches. Measurements and Main Results: Pulmonary expression of sGC, both at mRNA and protein level, was decreased in smokers without airflow limitation and in patients with COPD, and correlated with disease severity (FEV1{\%}). Inmice, exposure to CS reduced sGC, cyclic guanosine 59-monophosphate levels, and protein kinase G activity. sGCa12/2 mice exposed to CS exhibited bronchial hyperresponsiveness to serotonin. Activation of sGC by BAY 58-2667 restored the sGC signaling and attenuated bronchial hyperresponsiveness in CS-exposed mice. Conclusions: Down-regulation of sGC because of CS exposure might contribute to airflow limitation in COPD.",
keywords = "Chronic obstructive pulmonary disease, Cigarette smoking, Soluble guanylyl cyclase",
author = "Constantinos Glynos and Dupont, {Lisa L.} and Theodoros Vassilakopoulos and Andreas Papapetropoulos and Peter Brouckaert and Athanassios Giannis and Joos, {Guy F.} and Bracke, {Ken R.} and Brusselle, {Guy G.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1164/rccm.201210-1884OC",
language = "English (US)",
volume = "188",
pages = "789--799",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "7",

}

TY - JOUR

T1 - The role of soluble Guanylyl Cyclase in chronic obstructive pulmonary disease

AU - Glynos, Constantinos

AU - Dupont, Lisa L.

AU - Vassilakopoulos, Theodoros

AU - Papapetropoulos, Andreas

AU - Brouckaert, Peter

AU - Giannis, Athanassios

AU - Joos, Guy F.

AU - Bracke, Ken R.

AU - Brusselle, Guy G.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Rationale: Soluble guanylyl cyclase (sGC), a cyclic guanosine 59-monophosphategenerating enzyme, regulates smooth muscle toneandexerts antiinflammatoryeffects in animal modelsof asthma and acute lung injury. In chronic obstructive pulmonary disease (COPD), primarily caused by cigarette smoke (CS), lung inflammation persists and smooth muscle tone remains elevated, despite ample amounts of nitric oxide that could activate sGC. Objectives: To determine the expression and function of sGCin patients with COPD and in a murine model of COPD. Methods: Expression of sGCa1, a2, and b1 subunits was examined in lungs of never-smokers, smokers without airflow limitation, and patients with COPD; and in C57BL/6 mice after 3 days, 4 weeks, and 24 weeks of CS exposure. The functional role of sGC was investigated in vivo by measuring bronchial responsiveness to serotonin in mice using genetic and pharmacologic approaches. Measurements and Main Results: Pulmonary expression of sGC, both at mRNA and protein level, was decreased in smokers without airflow limitation and in patients with COPD, and correlated with disease severity (FEV1%). Inmice, exposure to CS reduced sGC, cyclic guanosine 59-monophosphate levels, and protein kinase G activity. sGCa12/2 mice exposed to CS exhibited bronchial hyperresponsiveness to serotonin. Activation of sGC by BAY 58-2667 restored the sGC signaling and attenuated bronchial hyperresponsiveness in CS-exposed mice. Conclusions: Down-regulation of sGC because of CS exposure might contribute to airflow limitation in COPD.

AB - Rationale: Soluble guanylyl cyclase (sGC), a cyclic guanosine 59-monophosphategenerating enzyme, regulates smooth muscle toneandexerts antiinflammatoryeffects in animal modelsof asthma and acute lung injury. In chronic obstructive pulmonary disease (COPD), primarily caused by cigarette smoke (CS), lung inflammation persists and smooth muscle tone remains elevated, despite ample amounts of nitric oxide that could activate sGC. Objectives: To determine the expression and function of sGCin patients with COPD and in a murine model of COPD. Methods: Expression of sGCa1, a2, and b1 subunits was examined in lungs of never-smokers, smokers without airflow limitation, and patients with COPD; and in C57BL/6 mice after 3 days, 4 weeks, and 24 weeks of CS exposure. The functional role of sGC was investigated in vivo by measuring bronchial responsiveness to serotonin in mice using genetic and pharmacologic approaches. Measurements and Main Results: Pulmonary expression of sGC, both at mRNA and protein level, was decreased in smokers without airflow limitation and in patients with COPD, and correlated with disease severity (FEV1%). Inmice, exposure to CS reduced sGC, cyclic guanosine 59-monophosphate levels, and protein kinase G activity. sGCa12/2 mice exposed to CS exhibited bronchial hyperresponsiveness to serotonin. Activation of sGC by BAY 58-2667 restored the sGC signaling and attenuated bronchial hyperresponsiveness in CS-exposed mice. Conclusions: Down-regulation of sGC because of CS exposure might contribute to airflow limitation in COPD.

KW - Chronic obstructive pulmonary disease

KW - Cigarette smoking

KW - Soluble guanylyl cyclase

UR - http://www.scopus.com/inward/record.url?scp=84886247128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886247128&partnerID=8YFLogxK

U2 - 10.1164/rccm.201210-1884OC

DO - 10.1164/rccm.201210-1884OC

M3 - Article

C2 - 23841447

AN - SCOPUS:84886247128

VL - 188

SP - 789

EP - 799

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 7

ER -